Our mission is to overcome human vascular diseases, and our vision is to present innovative treatments for genetic diseases. The three core technologies are target screening technology, capsid engineering technology, and global gene therapy CDMO technology. Therefore, Markherz Inc. aims to develop a high-stability therapeutic reagent by maximizing the efficiency of the gene transfer material by discovering the target transmitter for heart disease, brain disease, and solid cancer.
Company Details
- Founded
- -
- Address
- 815, Daewangpangyo-Ro, Sujeong-Gu, Seongnam-Si, Gyeonggi-Do, Republic Of Korea, 수정구,성남시 13449,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.markherzen.com/
- Keywords
- target screening technology, capsid engineering technology, global gene therapy CDMO technology.
- HQ
- 수정구, 성남시
Markherz Inc. Questions
Markherz Inc.'s website is http://www.markherzen.com/
Markherz Inc.'s LinkedIn profile is https://kr.linkedin.com/company/markherz
Markherz Inc.'s industry is
Biotechnology Research
Markherz Inc.'s top competitors are
Markherz,
金車關係事業 King Car Group,
Persatuan Aktuaris Indonesia,
Ecomms,
Willmeng Construction, Inc.,
Cae,
Sps Corporate,
Pt Superior Porcelain Sukses,
Imex Globiz Co.,ltd.,
Jagota Thailand.
Markherz Inc.'s categories are Biotechnology Research
Markherz Inc.'s founding year is 2021
